These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Diagnosis and therapy for beta2-microglobulin amyloidosis in the K/DOQI guideline]. Higuchi N; Maruyama H Clin Calcium; 2004 May; 14(5):744-9. PubMed ID: 15577036 [TBL] [Abstract][Full Text] [Related]
4. [Diagnosis of and therapy for patients with dialysis amyloidosis]. Homma N; Gejyo F Nihon Rinsho; 2004 Jun; 62 Suppl 6():348-52. PubMed ID: 15250322 [No Abstract] [Full Text] [Related]
5. May colchicine therapy be of value in the prevention of dialysis amyloidosis? Arik N; Yüksel H; Adam B; Akpolat T; Ozdemir O Nephron; 1996; 73(2):365-6. PubMed ID: 8773394 [No Abstract] [Full Text] [Related]
6. Does dialysis-associated amyloidosis resolve after transplantation? Nelson SR; Sharpstone P; Kingswood JC Nephrol Dial Transplant; 1993; 8(4):369-70. PubMed ID: 7685506 [No Abstract] [Full Text] [Related]
7. [The current procedures in the treatment of amyloidosis]. Vinogradova OM; Kochubeĭ LN; Chegaeva TV Ter Arkh; 1990; 62(6):139-45. PubMed ID: 2218913 [No Abstract] [Full Text] [Related]
8. Persistence of beta 2-microglobulin amyloid 10 years after renal transplantation. Kessler M; Aymard B; Pourel J Nephrol Dial Transplant; 1994; 9(3):333-4. PubMed ID: 8052450 [No Abstract] [Full Text] [Related]
9. Primary localized amyloidosis of the bladder: a case of AL (lambda) amyloid protein and combination therapy using dimethyl sulfoxide and cepharanthin. Nishiyama T; Gejyo F; Katayama Y; Takeda M; Takeda M; Sato S Urol Int; 1992; 48(2):228-31. PubMed ID: 1585522 [TBL] [Abstract][Full Text] [Related]
10. Role of conformational change in the C-terminus of beta2-microglobulin in dialysis-related amyloidosis. Kim J; Motomiya Y; Ueda M; Nakamura M; Misumi Y; Saito S; Ikemizu S; Misumi S; Ota K; Shinriki S; Kai H; Ando Y Ann Clin Biochem; 2008 Sep; 45(Pt 5):489-95. PubMed ID: 18753422 [TBL] [Abstract][Full Text] [Related]
12. Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts). Glenner GG N Engl J Med; 1980 Jun; 302(24):1333-43. PubMed ID: 6990257 [No Abstract] [Full Text] [Related]
13. [Amyloidosis; pathogenesis and therapy]. Witteman EM; Janssen HL; Hazenberg BP; Janssen S Ned Tijdschr Geneeskd; 1992 Nov; 136(47):2318-22. PubMed ID: 1461301 [No Abstract] [Full Text] [Related]
14. Alpha 2-macroglobulin protects some of the protein constituents of dialysis-associated amyloidosis from protease degradation. Gouin-Charnet A; Mourad G; Argilés A Biochem Biophys Res Commun; 1997 Feb; 231(1):48-51. PubMed ID: 9070217 [TBL] [Abstract][Full Text] [Related]
15. Beta 2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes. Floege J; Koch KM Clin Nephrol; 1994 Jul; 42 Suppl 1():S52-6. PubMed ID: 7923985 [No Abstract] [Full Text] [Related]